Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Lawrence Otto Klein

CEO at Oruka Therapeutics, Inc. (ORKA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $9.4M

Reported trades

Filed Stock Type Shares Price Value Since
Oct 2SEC ORKAOruka Therapeutics, Inc. Sell Plan 16,246931,882 held (−2%) $83.40 $1.4M -1.5%
Oct 2SEC ORKAOruka Therapeutics, Inc. Sell Plan 8,554923,328 held (−1%) $84.03 $719K -2.3%
Oct 2SEC ORKAOruka Therapeutics, Inc. Sell Plan 200923,128 held (−0%) $84.78 $17K -3.1%
Sep 15SEC ORKAOruka Therapeutics, Inc. Sell 2,452923,128 held (−0%) $95.71 $235K -14.2%
Sep 1SEC ORKAOruka Therapeutics, Inc. Sell Plan 6,604993,976 held (−1%) $90.79 $600K -9.6%
Sep 1SEC ORKAOruka Therapeutics, Inc. Sell Plan 63,596930,380 held (−6%) $91.90 $5.8M -10.7%
Sep 1SEC ORKAOruka Therapeutics, Inc. Sell Plan 4,800925,580 held (−1%) $92.44 $444K -11.2%
Jun 15SEC ORKAOruka Therapeutics, Inc. Sell 1,729925,580 held (−0%) $69.69 $120K +17.8%
Mar 17SEC ORKAOruka Therapeutics, Inc. Sell 1,729927,309 held (−0%) $41.30 $71K +98.8%
  • Sell

    CEO Lawrence Otto Klein sold $1.4M of ORKA at $83.40 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO Lawrence Otto Klein sold $719K of ORKA at $84.03 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO Lawrence Otto Klein sold $17K of ORKA at $84.78 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO Lawrence Otto Klein sold $600K of ORKA at $90.79 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO Lawrence Otto Klein sold $5.8M of ORKA at $91.90 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO Lawrence Otto Klein sold $444K of ORKA at $92.44 — pre-scheduled 10b5-1 plan sale.